ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,677,214 | +75.1% | 645,112 | +323.2% | 0.02% | +61.5% |
| Q3 2022 | $1,529,000 | +180.6% | 152,429 | +31.4% | 0.01% | +160.0% |
| Q2 2022 | $545,000 | +61.2% | 116,029 | +34.1% | 0.01% | +66.7% |
| Q1 2022 | $338,000 | -42.2% | 86,543 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $585,000 | – | 86,543 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $18,452 | 5.05% |
| Knollwood Investment Advisory, LLC | 1,678,510 | $9,063,954 | 3.55% |
| GUARDIAN POINT CAPITAL, LP | 300,000 | $1,620,000 | 1.28% |
| GREAT POINT PARTNERS LLC | 1,116,581 | $6,029,537 | 1.18% |
| RA Capital Management | 9,770,773 | $52,762,174 | 1.07% |
| Deep Track Capital, LP | 3,952,000 | $21,340,800 | 0.90% |
| Cheyne Capital Management (UK) LLP | 55,829 | $301,477 | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,115 | $1,593,621 | 0.46% |
| COMMODORE CAPITAL LP | 498,315 | $2,691 | 0.41% |
| Ikarian Capital, LLC | 254,945 | $1,376,703 | 0.33% |